248 related articles for article (PubMed ID: 17045982)
1. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.
Shaw JL; Grass L; Sotiropoulou G; Diamandis EP
Clin Biochem; 2007 Jan; 40(1-2):104-10. PubMed ID: 17045982
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N
Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391
[TBL] [Abstract][Full Text] [Related]
4. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
5. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues.
Luo LY; Grass L; Howarth DJ; Thibault P; Ong H; Diamandis EP
Clin Chem; 2001 Feb; 47(2):237-46. PubMed ID: 11159772
[TBL] [Abstract][Full Text] [Related]
6. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.
Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G
Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688
[TBL] [Abstract][Full Text] [Related]
8. Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay.
Kapadia C; Chang A; Sotiropoulou G; Yousef GM; Grass L; Soosaipillai A; Xing X; Howarth DH; Diamandis EP
Clin Chem; 2003 Jan; 49(1):77-86. PubMed ID: 12507963
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids.
Kishi T; Grass L; Soosaipillai A; Shimizu-Okabe C; Diamandis EP
Clin Chem; 2003 Jan; 49(1):87-96. PubMed ID: 12507964
[TBL] [Abstract][Full Text] [Related]
10. Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids.
Kishi T; Soosaipillai A; Grass L; Little SP; Johnstone EM; Diamandis EP
Clin Chem; 2004 Apr; 50(4):709-16. PubMed ID: 14764643
[TBL] [Abstract][Full Text] [Related]
11. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
12. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies.
Memari N; Grass L; Nakamura T; Karakucuk I; Diamandis EP
Biol Chem; 2006 Jun; 387(6):733-40. PubMed ID: 16800734
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids.
Obiezu CV; Shan SJ; Soosaipillai A; Luo LY; Grass L; Sotiropoulou G; Petraki CD; Papanastasiou PA; Levesque MA; Diamandis EP
Clin Chem; 2005 Aug; 51(8):1432-42. PubMed ID: 15961548
[TBL] [Abstract][Full Text] [Related]
14. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
Obiezu CV; Soosaipillai A; Jung K; Stephan C; Scorilas A; Howarth DH; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1232-40. PubMed ID: 12142379
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Yousef GM; Scorilas A; Katsaros D; Fracchioli S; Iskander L; Borgono C; Rigault de la Longrais IA; Puopolo M; Massobrio M; Diamandis EP
J Clin Oncol; 2003 Aug; 21(16):3119-26. PubMed ID: 12915603
[TBL] [Abstract][Full Text] [Related]
16. Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR).
Resnati M; Pallavicini I; Daverio R; Sidenius N; Bonini P; Blasi F
J Immunol Methods; 2006 Jan; 308(1-2):192-202. PubMed ID: 16386755
[TBL] [Abstract][Full Text] [Related]
17. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of human tissue kallikrein produced in Escherichia coli: biochemical comparison to the enzymatically inactive prokallikrein and methionyl kallikrein.
Lu HS; Hsu YR; Lu LI; Ruff D; Lyons D; Lin FK
Protein Expr Purif; 1996 Sep; 8(2):215-26. PubMed ID: 8812865
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma.
Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
Seiz L; Kotzsch M; Grebenchtchikov NI; Geurts-Moespot AJ; Fuessel S; Goettig P; Gkazepis A; Wirth MP; Schmitt M; Lossnitzer A; Sweep FC; Magdolen V
Biol Chem; 2010 Apr; 391(4):391-401. PubMed ID: 20180634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
